2023-05-10 10:12:58 ET
- SomaLogic ( NASDAQ: SLGC ) said that Biostar Technology will be the company’s first authorized site in China to offer the 7,000-plex SomaScan Assay and provide SomaScan data to their customers.
- CEO of Biostar and AccuraMed Steven Qiu. “We believe this partnership with SomaLogic will enable customers in China to make use of the SomaScan Assay as a powerful tool to study the mechanisms underlying the physiological and pathological processes in disease areas like cardiovascular and liver diseases, cancer and diabetes.”
For further details see:
SomaLogic expands to China with Biostar Technology